Inhibitors of melanogenesis increase toxicity of cyclophosphamide and lymphocytes against melanoma cells

No abstract is available for this paper.

• Publication year

  2009

• Venue

  International Journal of Cancer

• Publication date

  2009-03-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/ijc.24005PMID 19085934PMCID PMC2628959
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Coming of age of melanogenesis-related proteins.

  2009cited by this paper
• UV or Not UV: Metals Are The Answer

  2008cited by this paper
• Pathobiology of the sentinel node

  2008cited by this paper
• Epidemiologic support for melanoma heterogeneity using the surveillance, epidemiology, and end results program.

  2008cited by this paper
• Inhibition of melanogenesis as a radiation sensitizer for melanoma therapy

  2008cited by this paper
• Learning the ABCs of melanoma-initiating cells.

  2008cited by this paper
• New perspectives on melanoma pathogenesis and chemoprevention.

  2007cited by this paper
• Adjuvant Therapy of Melanoma

  2007cited by this paper
• Malignant melanoma in the 21st century, part 1: epidemiology, risk factors, screening, prevention, and diagnosis.

  2007cited by this paper
• Melanoma vaccines.

  2007cited by this paper
• Adoptive cell transfer therapy.

  2007cited by this paper
• Roadmap for new opportunities in melanoma research.

  2007cited by this paper
• Toll-like Receptors in Tumor Immunotherapy

  2007cited by this paper
• Management of metastatic melanoma.

  2007cited by this paper
• Randomized adjuvant therapy trials in melanoma: surgical and systemic.

  2007cited by this paper
• Markers and tissue resources for melanoma: meeting report.

  2006cited by this paper
• Modulation by IL-2 of CD70 and CD27 Expression on CD8+ T Cells: Importance for the Therapeutic Effectiveness of Cell Transfer Immunotherapy1

  2006cited by this paper
• Malignant melanoma: genetics and therapeutics in the genomic era.

  2006cited by this paper
• Biomarkers in melanoma: Stage III and IV disease

  2005cited by this paper
• Post-surgery adjuvant therapy with intermediate doses of interferon alfa 2b versus observation in patients with stage IIb/III melanoma (EORTC 18952): randomised controlled trial.

  2005cited by this paper
• Molecular diagnostics in melanoma.

  2005cited by this paper
• Melanin protects melanocytes and keratinocytes against H2O2-induced DNA strand breaks through its ability to bind Ca2+.

  2004cited by this paper
• Melanin pigmentation in mammalian skin and its hormonal regulation.

  2004cited by this paper
• Etiologic Pathogenesis of Melanoma

  2004cited by this paper
• Functional activity of serotoninergic and melatoninergic systems expressed in the skin

  2003cited by this paper
• Immunotherapy of melanoma.

  2003cited by this paper
• Melanogenesis and melanoma.

  2003cited by this paper
• European approach to adjuvant treatment of intermediate- and high-risk malignant melanoma.

  2002cited by this paper
• Evaluation of 5-S-cysteinyldopa as a marker of melanoma progression: 10 years’ experience

  2002cited by this paper
• Specific peptide‐mediated immunity against established melanoma tumors with dendritic cells requires IL‐2 and fetal calf serum‐free cell culture

  2002cited by this paper
• Tumor-associated carbohydrate antigens defining tumor malignancy: basis for development of anti-cancer vaccines.

  2001cited by this paper
• Malignant melanoma.

  2001cited by this paper
• Immunotherapeutic approaches for the treatment of malignant melanoma.

  2001cited by this paper
• What is the most promising strategy for the treatment of metastasizing melanoma?

  2000cited by this paper
• Cytokine-based therapy for melanoma: pre-clinical studies.

  2000cited by this paper
• Modification of melanogenesis in cultured human melanoma cells

  1999cited by this paper
• IL-1 beta, IL-2, IL-6 and TNF-alpha production by peripheral blood mononuclear cells from patients with Parkinson's disease.

  1999cited by this paper
• What's the use of generating melanin?

  1999cited by this paper
• IL-1β, IL-2, IL-6 and TNF-α production by peripheral blood mononuclear cells from patients with Parkinson's disease

  1999cited by this paper
• Biochemical control of melanogenesis and melanosomal organization.

  1999cited by this paper
• Current therapy for cutaneous melanoma.

  1999cited by this paper
• Inhibition of melanogenesis as an adjuvant strategy in the treatment of melanotic melanomas: selective review and hypothesis.

  1998cited by this paper
• Diversity of the cytotoxic melanoma-specific immune response: some CTL clones recognize autologous fresh tumor cells and not tumor cell lines.

  1997cited by this paper
• Adjuvant therapy for cutaneous malignant melanoma.

  1997cited by this paper
• Immunological gene therapy approaches for malignant melanoma. 1. Tumor-immunological background.

  1997cited by this paper
• Immunogenicity of membrane-bound gangliosides in viable whole-cell vaccines.

  1997cited by this paper
• Clinical promise of tumour immunology.

  1997cited by this paper
• Immunological gene therapy approaches for malignant melanoma. 2. Preclinical studies and clinical strategies.

  1997cited by this paper
• The immunotherapy of solid cancers based on cloning the genes encoding tumor-rejection antigens.

  1996cited by this paper
• Nonsteroidal anti-inflammatory drugs differentially regulate cytokine production in human lymphocytes: up-regulation of TNF, IFN-gamma and IL-2, in contrast to down-regulation of IL-6 production.

  1995cited by this paper
• Inhibition of melanogenesis for melanoma therapy?

  1994cited by this paper
• Melanogenesis as a targeting strategy against metastatic melanoma: a reassessment

  1994cited by this paper
• Melanocytes as "sensory" and regulatory cells in the epidermis.

  1993cited by this paper
• Measurement of eumelanin precursor metabolites in the urine as a new marker for melanoma metastases.

  1992cited by this paper
• Dopa inhibits induced proliferative activity of murine and human lymphocytes.

  1992cited by this paper
• Positive regulation of melanin pigmentation by two key substrates of the melanogenic pathway, L-tyrosine and L-dopa.

  1988cited by this paper
• The distribution of iron and iron binding proteins in spleen with reference to Hodgkin's disease.

  1986cited by this paper
• Studies on the Cloudman melanoma cell line as a model for the action of MSH.

  1985cited by this paper
• Characterization of melanogenesis and morphogenesis of melanosomes by physicochemical properties of melanin and melanosomes in malignant melanoma.

  1984cited by this paper
• Adjuvant therapy for melanoma.

  1983cited by this paper
• Tyrosinase activity in primary cell culture of amelanotic melanoma cells

  1983cited by this paper
• New regulators of melanin biosynthesis and the autodestruction of melanoma cells

  1980cited by this paper
• Malignant melanoma: an update.

  1980cited by this paper
• Immunotherapy for Melanoma

  1973cited by this paper

• Pmel17 Deficiency Affects Melanogenesis and Promotes Tumor Vascularization

  2026cites this paper
• Advances in melanoma immunotherapy: harnessing vaccination as a potential novel immunotherapeutic strategy.

  2026cites this paper
• The small molecule ML233 is a direct inhibitor of tyrosinase function

  2025cites this paper
• Phytochemical Profile and Cosmeceutical Potential of Leaf Extracts of Two Species of the Anacardiaceae Family from the Mediterranean Scrubland: Pistacia lentiscus L. and Pistacia atlantica Desf.

  2025cites this paper
• Recent advances in gene delivery for melanocyte-associated disorders.

  2025cites this paper
• HLA export by melanoma cells decoys cytotoxic T cells to promote immune evasion.

  2025cites this paper
• The small molecule ML233 is a direct inhibitor of tyrosinase function

  2025cites this paper
• Therapeutic Use of Integrin Signaling in Melanoma Cells: Physical Link with the Extracellular Matrix (ECM)

  2025cites this paper
• Transdermal delivery of Ultradeformable cationic liposomes complexed with miR211-5p (UCL-211) stabilizes BRAFV600E+ melanocytic nevi.

  2025cites this paper
• One shot, twice the impact: synergistic reactive oxygen species-activated prodrug and tyrosinase inhibition for enhanced melanoma photodynamic therapy

  2025cites this paper
• Melanogenesis inhibition by (2-Methylbutyryl) Shikonin, a naturally occurring naphthoquinone potentiates dacarbazine anti-melanoma efficacy via ROS mediated apoptotic pathway

  2025cites this paper
• Small-Molecule Tyrosinase Inhibitors for Treatment of Hyperpigmentation

  2025cites this paper
• Unravelling the role of melanogenesis in melanoma: oncogenic crosstalk and therapeutic prospects

  2025cites this paper
• Effects of Sinensetin, Eupatilin, and Jaceosidin on Human Melanogenesis: A Pilot Study

  2025cites this paper
• Enantiomeric Excess Bupivacaine in a Lavender Oil NLC Tested in a Melanoma Model: Prolonged Release and Anticancer Effect

  2025cites this paper
• THE REGULATORY EFFECTS OF VITAMINS A, B1, B2, B3, B12, C, D AND E ON SKIN HEALTH, IMMUNITY AND DISEASES

  2025cites this paper
• Tyrosinase Inhibitors as Melanoma Sensitizers: Boosting Therapeutic Efficacy

  2025cites this paper
• Inhibitory Effect on the Tyrosinase Activity and Low Cytotoxicity of Monounsaturated Long-Chain Chelating Fatty Ester.

  2025cites this paper
• Unveiling the Phytochemical Diversity and Bioactivity of Astragalus melanophrurius: A First Report Integrating Experimental and In Silico Approaches

  2025cites this paper
• Recycled melanoma-secreted melanosomes regulate tumor-associated macrophage diversification

  2024cites this paper
• Phytochemical Analysis and in vitro Anti-inflammatory, Anticancer Activities of Marrubium lutescens on Melanoma Cancer Cell Line and Molecular Docking Studies

  2024cites this paper
• Incorporating network diffusion and peak location information for better single-cell ATAC-seq data analysis

  2024cites this paper
• Study of the Effects of Novel Analogs of Calebin-A on Melanogenesis

  2024cites this paper
• Modeling Melanoma Heterogeneity In Vitro: Redox, Resistance and Pigmentation Profiles

  2024cites this paper
• Lepidium peruvianum as a Source of Compounds with Anticancer and Cosmetic Applications

  2024cites this paper
• Comparative Study of the Effects of Curcuminoids and Tetrahydrocurcuminoids on Melanogenesis: Role of the Methoxy Groups

  2024cites this paper
• Transdermal Delivery of Ultradeformable Cationic Liposomes Complexed with miR211-5p (UCL-211) Stabilizes BRAFV600E+ Melanocytic Nevi

  2024cites this paper
• Tyrosinase‐Woven Melanin Nets for Melanoma Therapy through Targeted Mitochondrial Tethering and Enhanced Photothermal Treatment

  2024cites this paper
• Complex Inhibitory Activity of Pentacyclic Triterpenoids against Cutaneous Melanoma In Vitro and In Vivo: A Literature Review and Reconstruction of Their Melanoma-Related Protein Interactome.

  2024cites this paper
• Design and synthesis of 4-amino-2',4'-dihydroxyindanone derivatives as potent inhibitors of tyrosinase and melanin biosynthesis in human melanoma cells.

  2024cites this paper
• The melano-macrophage: The black leukocyte of fish immunity.

  2024cites this paper
• Synthesis, fungal biotransformation, and evaluation of the antimicrobial potential of chalcones with a chlorine atom

  2024cites this paper
• Recent Advances and Progress on Melanin: From Source to Application

  2023cites this paper
• Spectroscopic analysis, kinetic mechanism, computational docking, and molecular dynamics of active metabolites from the aerial parts of Astragalus membranaceusBunge as tyrosinase inhibitors.

  2023cites this paper
• Hypomethylation of CD3D promoter induces immune cell infiltration and supports malignant phenotypes in uveal melanoma

  2023cites this paper
• Increased Histological Tumor Pigmentation in Uveal Melanoma Is Related to Eye Color and Loss of Chromosome 3/BAP1

  2023cites this paper
• Molecular Subtypes Based on PANoptosis Genes and Characteristics of Immune Infiltration in Cutaneous Melanoma.

  2023cites this paper
• Histopathologic abundance of pigmentation correlates with disease‐specific survival in malignant melanoma but is not independent of current AJCC pT stage

  2023cites this paper
• The Mixture of Natural Products SH003 Exerts Anti-Melanoma Effects through the Modulation of PD-L1 in B16F10 Cells

  2023cites this paper
• Novel Hydrogenated Derivatives of Chemically Modified Curcumin CMC2.24 Are Potent Inhibitors of Melanogenesis in an In Vitro Model: Influence of Degree of Hydrogenation

  2023cites this paper
• Therapeutic potential of marine peptides in malignant melanoma.

  2023cites this paper
• Natural tyrosinase enzyme inhibitors: A path from melanin to melanoma and its reported pharmacological activities.

  2023cites this paper
• Resorcinol-based hemiindigoid derivatives as human tyrosinase inhibitors and melanogenesis suppressors in human melanoma cells.

  2022cites this paper
• Melanosomal targeting via caveolin-1 dependent endocytosis mediates ZN(II) phthalocyanine phototoxic action in melanoma cells.

  2022cites this paper
• The Dark Side of Melanin Secretion in Cutaneous Melanoma Aggressiveness

  2022cites this paper
• Development and Validation of a Novel Survival Model for Cutaneous Melanoma Based on Necroptosis-Related Genes

  2022cites this paper
• Glycosylation of Methylflavonoids in the Cultures of Entomopathogenic Filamentous Fungi as a Tool for Obtaining New Biologically Active Compounds

  2022cites this paper
• MITF in Normal Melanocytes, Cutaneous and Uveal Melanoma: A Delicate Balance

  2022cites this paper
• Identification of key biomarkers and immune infiltration in sporadic vestibular schwannoma basing transcriptome-wide profiling.

  2022cites this paper
• In vitro anti-melanoma effect of polyphenolic compounds

  2022cites this paper
• Heterogeneity of tyrosine-based melanin anabolism regulates pulmonary and cerebral organotropic colonization microenvironment of melanoma cells

  2022cites this paper
• Targeting Melanin in Melanoma with Radionuclide Therapy

  2022cites this paper
• Identification of an endoplasmic reticulum stress-associated gene signature to predict the immune status and prognosis of cutaneous melanoma

  2022cites this paper
• Tyrosinase suppresses vasculogenic mimicry in human melanoma cells

  2022cites this paper
• The potential impact of melanosomal pH and metabolism on melanoma

  2022cites this paper
• Analysis of Melanoma Gene Expression Signatures at the Single-Cell Level Uncovers 45-Gene Signature Related to Prognosis

  2022influential citation
• Vegetable‐derived indole enhances the melanoma‐treating efficacy of chemotherapeutics

  2022cites this paper
• Amelanotic Uveal Melanomas Evaluated by Indirect Ophthalmoscopy Reveal Better Long-Term Prognosis Than Pigmented Primary Tumours—A Single Centre Experience

  2022cites this paper
• Necroptosis-associated classification combined with tumor microenvironment characteristic analysis of cutaneous melanoma

  2022cites this paper
• Melanoma, Melanin, and Melanogenesis: The Yin and Yang Relationship

  2022cites this paper
• Pistacia lentiscus L. Distilled Leaves as a Potential Cosmeceutical Ingredient: Phytochemical Characterization, Transdermal Diffusion, and Anti-Elastase and Anti-Tyrosinase Activities

  2022cites this paper
• Sustained pigmentation causes DNA damage and invokes translesion polymerase Polκ for repair in melanocytes

  2022cites this paper
• Single-Cell ATAC-seq analysis via Network Refinement with peaks location information

  2022cites this paper
• Role of ROS-mediated autophagy in melanoma

  2022cites this paper
• Neoantigen-Reactive T Cells: The Driving Force behind Successful Melanoma Immunotherapy

  2021cites this paper
• Ellagic acid as a potent anticancer drug: A comprehensive review on in vitro, in vivo, in silico, and drug delivery studies

  2021cites this paper
• Epstein-Barr Virus-induced Gene 3 as a Novel Biomarker in Metastatic Melanoma With Infiltrating CD8+ T Cells: A Study Based on The Cancer Genome Atlas (TCGA)

  2021cites this paper
• A 1,8-naphthalimide based fluorescent probe for sensing tyrosinase in zebrafish

  2021cites this paper
• CMAR_A_281920 925..939

  2021cites this paper
• Transient Receptor Potential channels, TRPV1 and TRPA1 in melanocytes synergize UV‐dependent and UV‐independent melanogenesis

  2021cites this paper
• Pigmentation Levels Affect Melanoma Responses to Coriolus versicolor Extract and Play a Crucial Role in Melanoma-Mononuclear Cell Crosstalk

  2021cites this paper
• Bioactive peptides from microalgae. Focus on anti-cancer and immunomodulating activity.

  2021cites this paper
• Milieu Relevance of Melanin’s Antiviral Effects and Interventions to the COVID-19 Pandemic

  2021cites this paper
• ANXA10 promotes melanoma metastasis by suppressing E3 ligase TRIM41-directed PKD1 degradation.

  2021cites this paper
• Expression analysis of candidate genes in vitiligo patients & effect of oxidative stress on melanocytes

  2021cites this paper
• Long Non-Coding RNA HOXA11-AS Modulates Proliferation, Apoptosis, Metastasis and EMT in Cutaneous Melanoma Cells Partly via miR-152-3p/ITGA9 Axis

  2021cites this paper
• From Proteomic Mapping to Invasion-Metastasis-Cascade Systemic Biomarkering and Targeted Drugging of Mutant BRAF-Dependent Human Cutaneous Melanomagenesis

  2021cites this paper
• Neogambogic acid induces apoptosis of melanoma B16 cells via the PI3K/Akt/mTOR signaling pathway.

  2020cites this paper
• Tumor Necrosis Factor Receptor-1 (p55) Deficiency Attenuates Tumor Growth and Intratumoral Angiogenesis and Stimulates CD8+ T Cell Function in Melanoma

  2020cites this paper
• Effect of Rosmarinic Acid and Ionizing Radiation on Glutathione in Melanoma B16F10 Cells: A Translational Opportunity

  2020cites this paper
• Caffeic Acid Phenethyl Ester Assisted by Reversible Electroporation—In Vitro Study on Human Melanoma Cells

  2020cites this paper
• In vitro antitumor and anti-angiogenic activities of a shrimp chondroitin sulfate.

  2020cites this paper
• Salinomycin induces autophagic cell death in salinomycin-sensitive melanoma cells through inhibition of autophagic flux

  2020cites this paper
• Multimodal Treatment of Advanced Mucosal Melanoma in the Era of Modern Immunotherapy

  2020cites this paper
• Melanogenesis Connection with Innate Immunity and Toll-Like Receptors

  2020influential citation
• In Vitro Antitumor Potential of Sulfated Polysaccharides from Seaweed Caulerpa cupressoides var. flabellata

  2020cites this paper
• Current Molecular Markers of Melanoma and Treatment Targets

  2020cites this paper
• Inherited variations in human pigmentation-related genes modulate cutaneous melanoma risk and clinicopathological features in Brazilian population

  2020cites this paper
• Transcriptional characterization of conjunctival melanoma identifies the cellular tumor microenvironment and prognostic gene signatures

  2020cites this paper
• Pectolinarigenin inhibits cell viability, migration and invasion and induces apoptosis via a ROS-mitochondrial apoptotic pathway in melanoma cells

  2020cites this paper
• Polymethoxyflavones from Gardenia oudiepe (Rubiaceae) induce cytoskeleton disruption-mediated apoptosis and sensitize BRAF-mutated melanoma cells to chemotherapy.

  2020cites this paper
• CMT-308, a Nonantimicrobial Chemically-Modified Tetracycline, Exhibits Anti-Melanogenic Activity by Suppression of Melanosome Export

  2020cites this paper
• Coriolus versicolor‐derived protein‐bound polysaccharides trigger the caspase‐independent cell death pathway in amelanotic but not melanotic melanoma cells

  2020influential citation
• Advances in the Design of Genuine Human Tyrosinase Inhibitors for Targeting Melanogenesis and Related Pigmentations.

  2020cites this paper
• Anti-Melanogenic Activity and Cytotoxicity of Pistacia vera Hull on Human Melanoma SKMEL-3 Cells.

  2020cites this paper
• Resveratrol-mediated inhibition of cyclooxygenase-2 in melanocytes suppresses melanogenesis through extracellular signal-regulated kinase 1/2 and phosphoinositide 3-kinase/Akt signalling.

  2019cites this paper
• Utilizing 808 nm laser for sensitizing of melanoma tumors to megavoltage radiation therapy

  2019cites this paper
• Melatonin exerts oncostatic capacity and decreases melanogenesis in human MNT‐1 melanoma cells

  2019cites this paper
• Vitamin A Enhances Macrophages Activity Against B16-F10 Malignant Melanocytes: A New Player for Cancer Immunotherapy?

  2019cites this paper
• A case report for severe hand-foot skin reaction caused by chemotherapy with actinomycin D in a patient with oculocutaneous albinism

  2019cites this paper